Cite

HARVARD Citation

    Hablot, J. et al. (2020). Tofacitinib treatment alters mucosal immunity and gut microbiota during experimental arthritis. Clinical and translational medicine. 10 (5), p. n/a. [Online]. 
  
Back to record